• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

在乳腺癌进展过程中,通过 DNA 甲基化导致 TNFSF7(CD70)的表观遗传沉默。

Epigenetic silencing of TNFSF7 (CD70) by DNA methylation during progression to breast cancer.

机构信息

Department of Biology, College of Science, Yonsei University, Seoul, 120-749, Korea.

出版信息

Mol Cells. 2010 Feb 28;29(2):217-21. doi: 10.1007/s10059-010-0052-9. Epub 2010 Jan 28.

DOI:10.1007/s10059-010-0052-9
PMID:20119871
Abstract

To escape the immune system, tumor cells may remove surface molecules such as the major histocompatibility complex (MHC) and co-stimulatory molecules, which are essential for recognition by lymphocytes. Down-regulation of the co-stimulatory molecules CD70 (TNFSF7) and CD80 may contribute to tumor cell survival; however, the mechanism of down-regulation of the TNFSF7 gene during tumorigenesis is poorly understood. Here we present evidence indicating that TNFSF7 gene expression is epigenetically down-regulated via DNA hypermethylation within its promoter region during progression in breast cancer cells in the isogenic MCF10 model. Bisulfite sequencing revealed that the CpG pairs at the proximal region of the TNFSF7 promoter are heavily methylated during progression of breast cancer cells but that methylation of the more distal sequences was not changed considerably. Thus, this epigenetic silencing of the TNFSF7 gene via hypermethylation of its proximal region may allow the benign and invasive MCF10 variants to escape immune surveillance.

摘要

为了逃避免疫系统,肿瘤细胞可能会去除表面分子,如主要组织相容性复合体 (MHC) 和共刺激分子,这些分子对于淋巴细胞的识别至关重要。共刺激分子 CD70 (TNFSF7) 和 CD80 的下调可能有助于肿瘤细胞的存活;然而,肿瘤发生过程中 TNFSF7 基因下调的机制还不清楚。在这里,我们提供的证据表明,在 MCF10 同基因模型中乳腺癌细胞的进展过程中,TNFSF7 基因通过其启动子区域内的 DNA 超甲基化而被表观遗传地下调。亚硫酸氢盐测序显示,在乳腺癌细胞的进展过程中,TNFSF7 启动子近端的 CpG 对高度甲基化,但更远端序列的甲基化变化不大。因此,这种通过其近端区域的高度甲基化导致的 TNFSF7 基因的表观遗传沉默可能使良性和侵袭性 MCF10 变体逃避免疫监视。

相似文献

1
Epigenetic silencing of TNFSF7 (CD70) by DNA methylation during progression to breast cancer.在乳腺癌进展过程中,通过 DNA 甲基化导致 TNFSF7(CD70)的表观遗传沉默。
Mol Cells. 2010 Feb 28;29(2):217-21. doi: 10.1007/s10059-010-0052-9. Epub 2010 Jan 28.
2
Epigenetic up-regulation of leukemia inhibitory factor (LIF) gene during the progression to breast cancer.在乳腺癌进展过程中白血病抑制因子(LIF)基因的表观遗传上调。
Mol Cells. 2011 Feb;31(2):181-9. doi: 10.1007/s10059-011-0020-z. Epub 2010 Dec 3.
3
Aberrant methylation and silencing of ARHI, an imprinted tumor suppressor gene in which the function is lost in breast cancers.ARHI基因(一种印记肿瘤抑制基因)的异常甲基化和沉默,该基因在乳腺癌中功能丧失。
Cancer Res. 2003 Jul 15;63(14):4174-80.
4
Tissue factor pathway inhibitor-2 was repressed by CpG hypermethylation through inhibition of KLF6 binding in highly invasive breast cancer cells.在高侵袭性乳腺癌细胞中,组织因子途径抑制剂-2通过抑制KLF6结合被CpG高甲基化所抑制。
BMC Mol Biol. 2007 Dec 3;8:110. doi: 10.1186/1471-2199-8-110.
5
Promoter methylation reduces C/EBPdelta (CEBPD) gene expression in the SUM-52PE human breast cancer cell line and in primary breast tumors.启动子甲基化降低了SUM-52PE人乳腺癌细胞系和原发性乳腺肿瘤中C/EBPδ(CEBPD)基因的表达。
Breast Cancer Res Treat. 2006 Jan;95(2):161-70. doi: 10.1007/s10549-005-9061-3. Epub 2005 Dec 2.
6
Correlation between the single-site CpG methylation and expression silencing of the XAF1 gene in human gastric and colon cancers.人胃癌和结肠癌中XAF1基因单位点CpG甲基化与表达沉默的相关性
Gastroenterology. 2006 Dec;131(6):1835-43. doi: 10.1053/j.gastro.2006.09.050. Epub 2006 Oct 1.
7
Pharmacologic reversion of epigenetic silencing of the PRKD1 promoter blocks breast tumor cell invasion and metastasis.PRKD1启动子表观遗传沉默的药理学逆转可阻断乳腺肿瘤细胞的侵袭和转移。
Breast Cancer Res. 2013 Aug 23;15(2):R66. doi: 10.1186/bcr3460.
8
DNA methylation-dependent silencing of CST6 in human breast cancer cell lines.人乳腺癌细胞系中 CST6 的 DNA 甲基化依赖性沉默
Lab Invest. 2006 Dec;86(12):1233-42. doi: 10.1038/labinvest.3700485. Epub 2006 Oct 16.
9
Hyper-methylation of the upstream CpG island shore is a likely mechanism of GPER1 silencing in breast cancer cells.上游CpG岛岸的高甲基化是乳腺癌细胞中GPER1沉默的一种可能机制。
Gene. 2017 May 30;614:65-73. doi: 10.1016/j.gene.2017.03.006. Epub 2017 Mar 7.
10
Frequent epigenetic inactivation of the receptor tyrosine kinase EphA5 by promoter methylation in human breast cancer.在人类乳腺癌中,受体酪氨酸激酶EphA5常因启动子甲基化而发生表观遗传失活。
Hum Pathol. 2010 Jan;41(1):48-58. doi: 10.1016/j.humpath.2009.06.007. Epub 2009 Sep 5.

引用本文的文献

1
Reprogramming the breast tumor immune microenvironment: cold-to-hot transition for enhanced immunotherapy.重编程乳腺肿瘤免疫微环境:从冷到热的转变以增强免疫治疗
J Exp Clin Cancer Res. 2025 Apr 25;44(1):131. doi: 10.1186/s13046-025-03394-8.
2
The CD70-CD27 axis in oncology: the new kids on the block.肿瘤学中的 CD70-CD27 轴:崭露头角的新势力。
J Exp Clin Cancer Res. 2022 Jan 6;41(1):12. doi: 10.1186/s13046-021-02215-y.
3
Exploring the Molecular Mechanism of the Drug-Treated Breast Cancer Based on Gene Expression Microarray.
基于基因表达微阵列探讨药物治疗乳腺癌的分子机制。
Biomolecules. 2019 Jul 15;9(7):282. doi: 10.3390/biom9070282.
4
Hypoxia-inducible factor-2 alpha up-regulates CD70 under hypoxia and enhances anchorage-independent growth and aggressiveness in cancer cells.缺氧诱导因子-2α在缺氧条件下上调CD70,并增强癌细胞的非锚定依赖性生长和侵袭性。
Oncotarget. 2018 Apr 10;9(27):19123-19135. doi: 10.18632/oncotarget.24919.
5
Expression of CD70 (CD27L) Is Associated With Epithelioid and Sarcomatous Features in IDH-Wild-Type Glioblastoma.CD70(CD27L)的表达与异柠檬酸脱氢酶(IDH)野生型胶质母细胞瘤的上皮样和肉瘤样特征相关。
J Neuropathol Exp Neurol. 2017 Aug 1;76(8):697-708. doi: 10.1093/jnen/nlx051.
6
CD80 down-regulation is associated to aberrant DNA methylation in non-inflammatory colon carcinogenesis.CD80下调与非炎症性结肠癌发生过程中的异常DNA甲基化有关。
BMC Cancer. 2016 Jul 4;16:388. doi: 10.1186/s12885-016-2405-z.
7
Repurposing L-Menthol for Systems Medicine and Cancer Therapeutics? L-Menthol Induces Apoptosis through Caspase 10 and by Suppressing HSP90.将L-薄荷醇用于系统医学和癌症治疗?L-薄荷醇通过半胱天冬酶10并抑制热休克蛋白90诱导细胞凋亡。
OMICS. 2016 Jan;20(1):53-64. doi: 10.1089/omi.2015.0118.
8
CD70: A Potential Target in Breast Cancer?CD70:乳腺癌的潜在靶点?
J Cancer. 2014 Oct 22;5(9):761-4. doi: 10.7150/jca.10360. eCollection 2014.
9
Epigenetic up-regulation of leukemia inhibitory factor (LIF) gene during the progression to breast cancer.在乳腺癌进展过程中白血病抑制因子(LIF)基因的表观遗传上调。
Mol Cells. 2011 Feb;31(2):181-9. doi: 10.1007/s10059-011-0020-z. Epub 2010 Dec 3.